Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01043263Phase 2Completed
A Phase 2 trial of axomadol in chronic low back pain (CLBP), sponsored by Grünenthal GmbH. Started Dec 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01043263.